Literature DB >> 29956105

Clinical Research on Alzheimer's Disease: Progress and Perspectives.

Bin-Lu Sun1, Wei-Wei Li1, Chi Zhu1, Wang-Sheng Jin1, Fan Zeng1, Yu-Hui Liu1, Xian-Le Bu1, Jie Zhu1, Xiu-Qing Yao2, Yan-Jiang Wang3,4.   

Abstract

Alzheimer's disease (AD), the most common type of dementia, is becoming a major challenge for global health and social care. However, the current understanding of AD pathogenesis is limited, and no early diagnosis and disease-modifying therapy are currently available. During the past year, significant progress has been made in clinical research on the diagnosis, prevention, and treatment of AD. In this review, we summarize the latest achievements, including diagnostic biomarkers, polygenic hazard score, amyloid and tau PET imaging, clinical trials targeting amyloid-beta (Aβ), tau, and neurotransmitters, early intervention, and primary prevention and systemic intervention approaches, and provide novel perspectives for further efforts to understand and cure the disease.

Entities:  

Keywords:  5-HT6 receptor antagonist; Alzheimer’s disease; Amyloid-beta; BACE1 inhibitor; Biomarker; Immunotherapy; Positron emission tomographic imaging; Primary prevention; Tau

Mesh:

Substances:

Year:  2018        PMID: 29956105      PMCID: PMC6246849          DOI: 10.1007/s12264-018-0249-z

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  51 in total

1.  Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.

Authors:  Wang-Sheng Jin; Lin-Lin Shen; Xian-Le Bu; Wei-Wei Zhang; Si-Han Chen; Zhi-Lin Huang; Jia-Xiang Xiong; Chang-Yue Gao; Zhifang Dong; Ya-Ni He; Zhi-An Hu; Hua-Dong Zhou; Weihong Song; Xin-Fu Zhou; Yi-Zheng Wang; Yan-Jiang Wang
Journal:  Acta Neuropathol       Date:  2017-05-05       Impact factor: 17.088

Review 2.  Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.

Authors:  Giovanni B Frisoni; Marina Boccardi; Frederik Barkhof; Kaj Blennow; Stefano Cappa; Konstantinos Chiotis; Jean-Francois Démonet; Valentina Garibotto; Panteleimon Giannakopoulos; Anton Gietl; Oskar Hansson; Karl Herholz; Clifford R Jack; Flavio Nobili; Agneta Nordberg; Heather M Snyder; Mara Ten Kate; Andrea Varrone; Emiliano Albanese; Stefanie Becker; Patrick Bossuyt; Maria C Carrillo; Chiara Cerami; Bruno Dubois; Valentina Gallo; Ezio Giacobini; Gabriel Gold; Samia Hurst; Anders Lönneborg; Karl-Olof Lovblad; Niklas Mattsson; José-Luis Molinuevo; Andreas U Monsch; Urs Mosimann; Alessandro Padovani; Agnese Picco; Corinna Porteri; Osman Ratib; Laure Saint-Aubert; Charles Scerri; Philip Scheltens; Jonathan M Schott; Ida Sonni; Stefan Teipel; Paolo Vineis; Pieter Jelle Visser; Yutaka Yasui; Bengt Winblad
Journal:  Lancet Neurol       Date:  2017-07-11       Impact factor: 44.182

3.  An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.

Authors:  Oskar Adolfsson; Maria Pihlgren; Nicolas Toni; Yvan Varisco; Anna Lucia Buccarello; Katia Antoniello; Sophie Lohmann; Kasia Piorkowska; Valerie Gafner; Jasvinder K Atwal; Janice Maloney; Mark Chen; Alvin Gogineni; Robby M Weimer; Deborah L Mortensen; Michel Friesenhahn; Carole Ho; Robert Paul; Andrea Pfeifer; Andreas Muhs; Ryan J Watts
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

4.  Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.

Authors:  Eric R Siemers; Karen L Sundell; Christopher Carlson; Michael Case; Gopalan Sethuraman; Hong Liu-Seifert; Sherie A Dowsett; Michael J Pontecorvo; Robert A Dean; Ronald Demattos
Journal:  Alzheimers Dement       Date:  2015-08-01       Impact factor: 21.566

Review 5.  Dementia prevention, intervention, and care.

Authors:  Gill Livingston; Andrew Sommerlad; Vasiliki Orgeta; Sergi G Costafreda; Jonathan Huntley; David Ames; Clive Ballard; Sube Banerjee; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Eric B Larson; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2017-07-20       Impact factor: 202.731

Review 6.  Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.

Authors:  Shieh-Yueh Yang; Ming-Jang Chiu; Ta-Fu Chen; Herng-Er Horng
Journal:  Neurol Ther       Date:  2017-07-21

7.  Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.

Authors:  Rahul S Desikan; Chun Chieh Fan; Yunpeng Wang; Andrew J Schork; Howard J Cabral; L Adrienne Cupples; Wesley K Thompson; Lilah Besser; Walter A Kukull; Dominic Holland; Chi-Hua Chen; James B Brewer; David S Karow; Karolina Kauppi; Aree Witoelar; Celeste M Karch; Luke W Bonham; Jennifer S Yokoyama; Howard J Rosen; Bruce L Miller; William P Dillon; David M Wilson; Christopher P Hess; Margaret Pericak-Vance; Jonathan L Haines; Lindsay A Farrer; Richard Mayeux; John Hardy; Alison M Goate; Bradley T Hyman; Gerard D Schellenberg; Linda K McEvoy; Ole A Andreassen; Anders M Dale
Journal:  PLoS Med       Date:  2017-03-21       Impact factor: 11.069

Review 8.  Developing novel blood-based biomarkers for Alzheimer's disease.

Authors:  Heather M Snyder; Maria C Carrillo; Francine Grodstein; Kim Henriksen; Andreas Jeromin; Simon Lovestone; Michelle M Mielke; Sid O'Bryant; Manual Sarasa; Magnus Sjøgren; Holly Soares; Jessica Teeling; Eugenia Trushina; Malcolm Ward; Tim West; Lisa J Bain; Diana W Shineman; Michael Weiner; Howard M Fillit
Journal:  Alzheimers Dement       Date:  2014-01       Impact factor: 21.566

Review 9.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

10.  Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.

Authors:  Gordon K Wilcock; Serge Gauthier; Giovanni B Frisoni; Jianping Jia; Jiri H Hardlund; Hans J Moebius; Peter Bentham; Karin A Kook; Bjoern O Schelter; Damon J Wischik; Charles S Davis; Roger T Staff; Vesna Vuksanovic; Trevor Ahearn; Luc Bracoud; Kohkan Shamsi; Ken Marek; John Seibyl; Gernot Riedel; John M D Storey; Charles R Harrington; Claude M Wischik
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more
  30 in total

1.  Is Alzheimer's Disease Transmissible in Humans?

Authors:  Xian-Le Bu; Wei-Wei Li; Yan-Jiang Wang
Journal:  Neurosci Bull       Date:  2019-04-29       Impact factor: 5.203

2.  Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer's Disease.

Authors:  Yanjun Lu; Lu Tan; Xiong Wang
Journal:  Neurosci Bull       Date:  2019-03-18       Impact factor: 5.203

3.  New Insights into the Dysfunctions of Pericytes and Neurovascular Units in Neurodegenerative Diseases.

Authors:  Qiang Liu; Wei-Jye Lin; Yamei Tang
Journal:  Neurosci Bull       Date:  2020-08-03       Impact factor: 5.203

4.  Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in a Chinese Cohort.

Authors:  Wei-Wei Li; Zhen Wang; Dong-Yu Fan; Ying-Ying Shen; Dong-Wan Chen; Hui-Yun Li; Ling Li; Heng Yang; Yu-Hui Liu; Xian-Le Bu; Wang-Sheng Jin; Fan Zeng; Zhi-Qiang Xu; Jin-Tai Yu; Li-Yong Chen; Yan-Jiang Wang
Journal:  Neurosci Bull       Date:  2020-02-18       Impact factor: 5.203

5.  Meningeal Lymphatic Vessels: A Drain of the Brain Involved in Neurodegeneration?

Authors:  Yuan Cheng; Yan-Jiang Wang
Journal:  Neurosci Bull       Date:  2020-01-01       Impact factor: 5.203

6.  AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Xiumin Zhang; Fang Zhao; Chenfang Wang; Jun Zhang; Yu Bai; Fang Zhou; Zhaojun Wang; Meina Wu; Wei Yang; Junhong Guo; Jinshun Qi
Journal:  Neurosci Bull       Date:  2019-10-12       Impact factor: 5.203

7.  Single-Cell RNA Sequencing Reveals Cell-Type-Specific Mechanisms of Neurological Diseases.

Authors:  Zhen-Ge Luo; Jian Peng; Ting Li
Journal:  Neurosci Bull       Date:  2020-04-15       Impact factor: 5.203

8.  Early Intervention in Alzheimer's Disease: How Early is Early Enough?

Authors:  Dong-Yu Fan; Yan-Jiang Wang
Journal:  Neurosci Bull       Date:  2019-09-07       Impact factor: 5.203

9.  Apolipoprotein E Drives Early Blood-Brain Barrier Damage in Alzheimer's Disease.

Authors:  Qianqian Zhang; Chunming Xie
Journal:  Neurosci Bull       Date:  2020-10-17       Impact factor: 5.203

Review 10.  Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives.

Authors:  Bin-Lu Sun; Yang Chen; Dong-Yu Fan; Chi Zhu; Fan Zeng; Yan-Jiang Wang
Journal:  Sci China Life Sci       Date:  2020-10-23       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.